Product Program year 2020 Source: CMS Open Payments

Trifecta Tissue Heart Valve

Device Cardiac Arrhythmias and Heart Failure

Open in the dashboard

General payments

$137,650

339 payments

Research payments

$0

0 payments

Through program year 2020, $137,650 in general payments and $0 in research payments were reported against Trifecta Tissue Heart Valve (Cardiac Arrhythmias and Heart Failure).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $117,554 247
2019 General $20,096 92

Breakdown

Who paid General payments · program years 2019–2020
  1. Abbott Laboratories $137,650 339 payments
Top recipients General payments · program year 2020
  1. United Hospital Teaching hospital · MN $85,900 73% · 173 payments
  2. Danny Ramzy Thoracic Surgery (Cardiothoracic Vascular Surgery) · Houston, TX $27,700 24% · 11 payments
  3. Jose Navia Thoracic Surgery (Cardiothoracic Vascular Surgery) · Weston, FL $1,500 1% · 1 payment
  4. Marc Sakwa Thoracic Surgery (Cardiothoracic Vascular Surgery) · Long Beach, CA $360 <1% · 2 payments
  5. Jeffrey Altshuler Thoracic Surgery (Cardiothoracic Vascular Surgery) · Royal Oak, MI $360 <1% · 2 payments

The top 5 of 35 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Thoracic Surgery (Cardiothoracic Vascular Surgery) $31,498 100% · 29 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $48 <1% · 1 practitioner
  3. Internal Medicine $33 <1% · 1 practitioner
  4. Interventional Cardiology Internal Medicine $28 <1% · 1 practitioner
  5. Surgery $25 <1% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Minnesota $85,900 73% · 1 recipient
  2. California $27,903 24% · 7 recipients
  3. Ohio $1,522 1% · 2 recipients
  4. Georgia $768 <1% · 9 recipients
  5. Michigan $719 <1% · 2 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

339 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record